UKONIQ is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Tg Therapeutics, Inc.. The primary component is Umbralisib Tosylate.
| Product ID | 73150-200_6f6fcaa4-e82f-4850-bf75-b5806f0478af |
| NDC | 73150-200 |
| Product Type | Human Prescription Drug |
| Proprietary Name | UKONIQ |
| Generic Name | Umbralisib |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2021-02-05 |
| Marketing Category | NDA / NDA |
| Application Number | NDA213176 |
| Labeler Name | TG Therapeutics, Inc. |
| Substance Name | UMBRALISIB TOSYLATE |
| Active Ingredient Strength | 260 mg/1 |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2021-02-05 |
| NDC Exclude Flag | N |
| Sample Package? | N |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() UKONIQ 88711946 not registered Live/Pending |
TG Therapeutics 2019-12-02 |